XML 31 R20.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 7 - Stockholders' Equity (Tables)
6 Months Ended
Dec. 31, 2018
Notes Tables  
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
   
Weighted
Average,
December 31,
2018
   
 
Range,
December 31,
2018
   
Weighted
Average,
December 31,
2017
   
 
Range,
December 31,
2017
 
Volatility
   
70%
     
63%
-
76%
     
73%
     
73%
 
Dividend yield
   
-
     
 
-
 
     
-
     
-
 
Risk-free interest rate
   
2.73%
     
2.68%
-
2.78%
     
1.75%
     
1.75%
 
Expected term (years)
   
3.9
     
3.4
to
4.3
     
3
     
3
 
Share-based Compensation, Stock Options, Activity [Table Text Block]
   
 
 
 
 
Options
   
 
Weighted-
Average
Exercise
Price
   
Weighted-
Average
Remaining
Contractual
Life
   
 
 
Aggregate
Intrinsic
Value
 
Outstanding at July 1, 2018
   
6,827,225
    $
1.11
     
3.8
    $
-
 
Granted
   
325,000
     
0.68
     
 
     
 
 
Exercised
   
-
     
-
     
 
     
 
 
Forfeited
   
-
     
-
     
 
     
 
 
Expired
   
-
     
-
     
 
     
 
 
Outstanding at December 31, 2018
   
7,152,225
    $
1.10
     
3.5
    $
36,675
 
Exercisable at December 31, 2018
   
7,002,225
    $
1.11
     
3.6
    $
23,175
 
Schedule of Nonvested Share Activity [Table Text Block]
   
 
 
Options
   
Weighted Average
Grant-Date Fair
Value
 
Nonvested at July 1, 2018
   
-
    $
-
 
Granted
   
325,000
     
0.36
 
Vested
   
(175,000
)    
0.46
 
Nonvested at December 31, 2018
   
150,000
    $
0.25
 
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block]
   
Three
months
ended
December 31,
2018
   
Three
months
ended
December 31,
2017
   
Six months
ended
December 31,
2018
   
Six months
ended
December 31,
2017
 
General and administrative:
                               
Fair value of stock bonuses expensed
  $
-
    $
3,090
    $
-
    $
7,223
 
Change in fair value from modification of option terms
   
-
     
243,761
     
211,185
     
243,761
 
Change in fair value from modification of warrant terms
   
-
     
156,865
     
118,233
     
156,865
 
Fair value of stock options expensed
   
22,500
     
97,350
     
92,125
     
99,650
 
Total
  $
22,500
    $
501,066
    $
421,543
    $
507,499
 
                                 
Research and development:
                               
Fair value of stock bonus expensed
  $
-
    $
8,071
    $
-
    $
15,098
 
Change in fair value from modification of option terms
   
-
     
105,895
     
11,115
     
105,895
 
Change in fair value from modification of warrant terms
   
-
     
132,677
     
44,793
     
132,677
 
Fair value of stock options expensed
   
-
     
-
     
25,875
     
-
 
Total
  $
-
    $
246,643
    $
81,783
    $
253,670